West Michigan Advisors’s Insmed INSM Stock Holding History

West Michigan Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,418	Closed	-$2.68M	–	310
2025 Q4	$2.68M	Sell	15,418 -2,201	-12%	-$402K	0.62%	48
2025 Q3	$2.54M	Buy	+17,619	New	+$2.16M	0.61%	46

Other funds holding INSM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

West Michigan Advisors's INSM Position: Q1 2026 in Review

West Michigan Advisors sold out of Insmed (INSM) in Q1 2026, closing a stake of 15,418 shares — an estimated $2.68M sold.

West Michigan Advisors first reported a position in INSM in Q3 2025 and held it in 2 quarters. The position peaked at $2.68M in Q4 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

West Michigan Advisors reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
West Michigan Advisors sold 15,418 Insmed shares in Q1 2026, an estimated $2.68M.
West Michigan Advisors first reported a position in Insmed in Q3 2025 and held it in 2 quarters.
West Michigan Advisors's Insmed position peaked at $2.68M in Q4 2025.
673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on West Michigan Advisors's 13F filing for Q1 2026, filed 5 May 2026.